New CRISPR/Cas9 technique corrects cystic fibrosis in cultured human stem cells
Researchers from the group of Hans Clevers (Hubrecht Institute) corrected mutations that cause cystic fibrosis in cultured human stem cells. In collaboration with the UMC Utrecht and Oncode Institute, they used a technique called prime…